Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

RSS icon
COVID TEST

American Medical Association calls out ‘confusing, counterproductive’ quarantine guidance from CDC

The association underscored that a negative test should be required to end isolation after testing positive.

COVID-19 vaccination during pregnancy is not associated with adverse outcomes

Those who received a vaccine were not linked to higher risks of preterm or small-for-gestational-age birth, according to a study from the CDC.

FDA authorizes Pfizer COVID-19 booster for 12- to 15-year-olds

The administration also shortened the mandatory wait time to receive a third shot from six to five months after completing a second dose.

Israel will begin offering a fourth dose of COVID-19 vaccine

High risk patients such as people over 60, the immunocompromised and healthcare workers will soon be eligible for another shot.

Thumbnail

FDA authorizes Pfizer’s COVID-19 pill

Paxlovid becomes the first treatment for the coronavirus taken in pill form, the federal agency announced.

Thumbnail

Biden administration announces new actions to help hospitals keep up with omicron

The feds are making a large push to expand testing, setting up new sites across the U.S. and sending 500 million free kits to Americans beginning Jan. 1.

JPMorgan moves annual healthcare conference online following omicron concerns

Biotech giants Moderna and Amgen both recently dropped out of the in-person meeting, which was set to take place next month in San Francisco.

Thumbnail

Pfizer says its pill remains 89% effective against COVID-19 in final study results

The health giant also noted that the antiviral worked in lab studies against the omicron variant.

Displaying 481 - 488 of 713

Around the web

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met. 

AI in Healthcare
Healthcare AI regulation needs nuance, balance: Research review

When regulating AI-equipped medical devices, the FDA might take a page from the Department of Transportation’s playbook for overseeing AI-equipped vehicles. These run the gamut from assisting human drivers to fully taking the wheel.